IL-7/Anti-IL-7 mAb complexes restore T cell development and induce homeostatic T cell expansion without lymphopenia

被引:105
作者
Boyman, Onur [1 ]
Ramsey, Chris [1 ]
Kim, David M. [1 ]
Sprent, Jonathan [2 ]
Surh, Charles D. [1 ]
机构
[1] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[2] St Vincents Hosp, Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia
关键词
D O I
10.4049/jimmunol.180.11.7265
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IL-7, a member of the common gamma-chain family of cytokines, is essential for B and T lymphocyte development and homeostasis of mature T cell subsets. Thus, naive and memory T cells are both dependent on IL-7 for survival and homeostatic proliferation under lymphopenic conditions. In line with prior findings with IL-2, we show in this study that the biological activity of IL-7 in vivo is greatly increased by association with anti-IL-7 mAb. Under in vivo conditions, IL-7/mAb complexes displayed 50- to 100-fold higher activity than free IL-7 and induced massive expansion of pre-B cells. IL-7/mAb complexes also increased thymopoiesis in normal mice and restored thymopoeisis in IL-7-deficient mice. For mature T cells, IL-7/mAb complexes induced marked homeostatic proliferation of both naive and memory CD4(+) and CD8(+) cell subsets even under normal T cell-replete conditions. Finally, IL-7/mAb complexes were able to enhance the magnitude of the primary response of Ag-specific naive CD8(+) cells. The strong stimulatory activity of IL-7/mAb complexes could be useful for treatment of immunodeficiency and cancer.
引用
收藏
页码:7265 / 7275
页数:11
相关论文
共 69 条
[1]   High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: Analysis of 270 patients treated between 1985 and 1993 [J].
Atkins, MB ;
Lotze, MT ;
Dutcher, JP ;
Fisher, RI ;
Weiss, G ;
Margolin, K ;
Abrams, J ;
Sznol, M ;
Parkinson, D ;
Hawkins, M ;
Paradise, C ;
Kunkel, L ;
Rosenberg, SA .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) :2105-2116
[2]   γδ T cell homeostasis is controlled by IL-7 and IL-15 together with subset-specific factors [J].
Baccala, R ;
Witherden, D ;
Gonzalez-Quintial, R ;
Dummer, W ;
Surh, CD ;
Havran, WL ;
Theofilopoulos, AN .
JOURNAL OF IMMUNOLOGY, 2005, 174 (08) :4606-4612
[3]  
Bolotin E, 1996, BLOOD, V88, P1887
[4]   Selective stimulation of T cell subsets with antibody-cytokine immune complexes [J].
Boyman, O ;
Kovar, M ;
Rubinstein, MP ;
Surh, CD ;
Sprent, J .
SCIENCE, 2006, 311 (5769) :1924-1927
[5]   An intense form of homeostatic proliferation of naive CD8+ cells driven by IL-2 [J].
Cho, Jae-Ho ;
Boyman, Onur ;
Kim, Hee-Ok ;
Hahm, Bumsuk ;
Rubinstein, Mark P. ;
Ramsey, Chris ;
Kim, David M. ;
Surh, Charles D. ;
Sprent, Jonathan .
JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (08) :1787-1801
[6]  
CONLON PJ, 1989, BLOOD, V74, P1368
[7]   AN ANTI-IL-2 ANTIBODY INCREASES SERUM HALFLIFE AND IMPROVES ANTITUMOR EFFICACY OF HUMAN RECOMBINANT INTERLEUKIN-2 [J].
COURTNEY, LP ;
PHELPS, JL ;
KARAVODIN, LM .
IMMUNOPHARMACOLOGY, 1994, 28 (03) :223-232
[8]   Cutting edge:: Self-peptides drive the peripheral expansion of CD4+CD25+ regulatory T cells [J].
Cozzo, C ;
Larkin, J ;
Caton, AJ .
JOURNAL OF IMMUNOLOGY, 2003, 171 (11) :5678-5682
[9]   Immunocytokines: amplification of anti-cancer immunity [J].
Davis, CB ;
Gillies, SD .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2003, 52 (05) :297-308
[10]   Antibody-cytokine fusion proteins: innovative weapons in the war against cancer [J].
Dela Cruz, JS ;
Huang, TH ;
Penichet, ML ;
Morrison, SL .
CLINICAL AND EXPERIMENTAL MEDICINE, 2004, 4 (02) :57-64